The Bacille Calmette-Guerin (BCG) vaccine offers limited protection against tuberculosis (TB). In the UK it is given to high-risk infants. Until 2005 it was also routinely given to children at the age of 13 years.

The BCG vaccine does not prevent primary infection with tuberculosis or prevent the reactivation of latent TB. It does not provide reliable protection against any forms of TB in adults. It is still used because it is protective against severe diseases in children, particularly TB meningitis and disseminated TB in children. It is thought to prevent 60 - 80% of cases of TB meningitis in children who received BCG as neonates.

The Greenbook currently advises that the vaccine is administered to the following groups (below is summary, please see the link for more details):

The vaccine contains live attenuated Mycobacterium bovis. It also offers limited protection against leprosy.

Administration

Contraindications